Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_30979d9e827a8f605b4b586951390cde http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0fc19d8d6ba9ad5c1fa5770341472b56 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4743 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-27 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
filingDate |
1995-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2002-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e636086370919d319dafc772a34c9c5a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d985f90c36e271043e84e0521946645c |
publicationDate |
2002-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-6369029-B1 |
titleOfInvention |
Method of stimulating osteogenesis using a c-terminally truncated insulin-like growth factor binding protein-5 (IGFBP-5) |
abstract |
Methods for stimulating osteogenesis using C-terminally truncated insulin-like growth factor binding protein-5 (IGFBP-5) compounds and derivatives thereof are described. The IGFBP-5 polypeptides used in the methods are mitogenic and can be combined in compositions with insulin-like growth factor (IGF). |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7592177-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008214541-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7348154-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7951592-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7351545-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007020709-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2487735-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9334481-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007020698-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8309555-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007254884-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008199886-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7273864-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004035132-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010022533-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7192738-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005176707-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005148035-A1 |
priorityDate |
1992-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |